Physician profile
Randy Rowlands
NPI 1417156514
$1,383.87
in general payments reported to CMS, 2019-2025
15 companies · $390 in 2025
The $390 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $156 · 2020: $111 · 2021: $263 · 2022: $464 · 2025: $390.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $390.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $390.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $752.86 | 2020-2022 | |
| Allergan, INC. | $128.50 | 2019 | |
| Viatris Specialty LLC | $112.48 | 2025 | Yupelri |
| La Jolla Pharmaceutical Company | $85.16 | 2022 | |
| Exact Sciences Corporation | $74.32 | 2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $54.08 | 2025 | Mounjaro, Zepbound |
| Novo Nordisk INC | $33.00 | 2025 | Wegovy |
| Sanofi-Aventis U.S. LLC | $30.06 | 2019-2025 | |
| Neurocrine Biosciences, INC. | $20.00 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $17.92 | 2025 | |
| Sequel Med Tech, LLC | $16.14 | 2025 | Twiist |
| Medtronic, INC. | $15.99 | 2025 | Minimed 780g |
| Teva Pharmaceuticals USA, INC. | $15.74 | 2025 | Austedo Xr |
| Exeltis, USA INC. | $14.68 | 2025 | Slynd |
| Abbvie INC. | $12.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Randy Rowlands listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.